Nalaganje...
The impact of design and performance in PSA screening: differences between ERSPC centers
The European Randomized study of Screening for Prostate Cancer (ERSPC) has shown a 20% relative reduction in prostate cancer mortality after 16 years (rate ratio RR 0.80), but centers varied by attendance, screen interval, biopsy compliance, contamination in the control arm and treatments. We used a...
Shranjeno v:
| izdano v: | Eur Urol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6800079/ https://ncbi.nlm.nih.gov/pubmed/31031050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.04.007 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|